EUDA Health Holdings Limited (EUDA) - Total Liabilities
Based on the latest financial reports, EUDA Health Holdings Limited (EUDA) has total liabilities worth $5.85 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EUDA Health Holdings Limited (EUDA) cash flow conversion to assess how effectively this company generates cash.
EUDA Health Holdings Limited - Total Liabilities Trend (2020–2024)
This chart illustrates how EUDA Health Holdings Limited's total liabilities have evolved over time, based on quarterly financial data. Check EUDA Health Holdings Limited (EUDA) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
EUDA Health Holdings Limited Competitors by Total Liabilities
The table below lists competitors of EUDA Health Holdings Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PAKERS.Co.Ltd
KQ:065690
|
Korea | ₩35.24 Billion |
|
Aqua Metals Inc
NASDAQ:AQMS
|
USA | $4.94 Million |
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
Indonesia | Rp421.65 Billion |
|
Cardiex Ltd
AU:CDX
|
Australia | AU$10.39 Million |
|
INVO Fertility, Inc.
NASDAQ:IVF
|
USA | $12.98 Million |
|
Origin Agritech Ltd
NASDAQ:SEED
|
USA | $151.71 Million |
|
Indiana Resources Ltd
AU:IDA
|
Australia | AU$3.04 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down EUDA Health Holdings Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EUDA stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.76 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EUDA Health Holdings Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EUDA Health Holdings Limited (2020–2024)
The table below shows the annual total liabilities of EUDA Health Holdings Limited from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.30 Million | -51.07% |
| 2023-12-31 | $8.79 Million | -69.82% |
| 2022-12-31 | $29.14 Million | +293.79% |
| 2021-12-31 | $7.40 Million | +19.42% |
| 2020-12-31 | $6.20 Million | -- |
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.